Clinical Trial: A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Depressive Disorder, Major
Study Type: INTERVENTIONAL
Official Title: A Phase II, 6-week, Multicenter, Randomized, Double Blind (Patient and Investigator) or Masked, Placebo Controlled, Dose-finding Trial to Evaluate the Efficacy, Tolerability, and Safety of Different D
Brief Summary:
This study is open to adults between 18 and 65 with a type of depression (major depressive disorder) for whom previous treatments for depression did not work.The purpose of the study is to find out whether a medicine called BI 1569912 helps people with depression.Participants continue their standard therapy throughout the study.Participants are put into 4 groups by chance.3 of the 4 groups take different doses of BI 1569912. 1 group takes placebo.Placebo tablets looks like BI 1569912 but do not contain any…
Read more